T. Rowe Price Associates, Inc. 13D and 13G filings for West Pharmaceutical Services, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 12:37 pm Sale | 2022-12-31 | 13G | West Pharmaceutical Services, Inc. WST | T. Rowe Price Associates, Inc. | 2,301,161 3.100% | -3,940,740 (-63.13%) | Filing |
| 2022-02-14 2:34 pm Purchase | 2021-12-31 | 13G | West Pharmaceutical Services, Inc. WST | T. Rowe Price Associates, Inc. | 6,241,901 8.400% | 1,617,654 (+34.98%) | Filing |
| 2021-02-16 12:23 pm Sale | 2020-12-31 | 13G | West Pharmaceutical Services, Inc. WST | T. Rowe Price Associates, Inc. | 4,624,247 6.200% | -2,206,742 (-32.30%) | Filing |